# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103535
Filing Date
2025-08-06
Accepted
2025-08-06 07:15:26
Documents
106
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mnkd-20250630.htm iXBRL | 10-Q | 3837021
2 | EX-10.1 | mnkd-ex10_1.htm | EX-10.1 | 80628
3 | EX-10.2 | mnkd-ex10_2.htm | EX-10.2 | 1645736
4 | EX-31.1 | mnkd-ex31_1.htm | EX-31.1 | 15331
5 | EX-31.2 | mnkd-ex31_2.htm | EX-31.2 | 15330
6 | EX-32.1 | mnkd-ex32_1.htm | EX-32.1 | 11040
7 | EX-32.2 | mnkd-ex32_2.htm | EX-32.2 | 11048
| Complete submission text file | 0000950170-25-103535.txt |  | 19255337

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mnkd-20250630.xsd | EX-101.SCH | 2537056
109 | EXTRACTED XBRL INSTANCE DOCUMENT | mnkd-20250630_htm.xml | XML | 3464279

Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 251187436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)